# LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/ly3437943-a-novel-triple-glucagon-gip-and-glp-1-receptor-agonist-for-glycemic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Tamer Coşkun,Shweta Urva,William C. Roell,Hongchang Qu,Corina Loghin,Julie S. Moyers,Libbey S. O’Farrell,Daniel A. Briere,Kyle W. Sloop,Melissa K. Thomas,Valentina Pirro,David B. Wainscott,Francis S. Willard,Matthew Abernathy,LaRonda L. Morford,Yu Du,Charles Benson,Ruth E. Gimeno,Axel Haupt,Zvonko Miličević |
| Citations | 286 |
| DOI | 10.1016/j.cmet.2022.07.013 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.cell.com/article/S1550413122003126/pdf |
| OpenAlex ID | https://openalex.org/W4292242922 |
| PMID | 35985340 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Axel Haupt](https://scholariq.org/researchers/axel-haupt/)

## Paper journal

- [Cell Metabolism](https://scholariq.org/journals/cell-metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Pharmacology and Obesity Treatment](https://scholariq.org/topics/pharmacology-and-obesity-treatment/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.